International Journal of Cancer Management

Published by: Kowsar

Stevens-Johnson Syndrome Patient Received Combination Chemotherapy Gemcitabine, Cisplatin, and 5-FU for Biliary Tract Cancer

Mozaffar Aznab 1 , * and Mansour Khazaei 2
Authors Information
1 Medical Oncologist-Hematologist, Associate Professor, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
2 Assistant Professor, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: June 2016, 9 (3); e4211
  • Published Online: June 13, 2016
  • Article Type: Case Report
  • Received: October 7, 2015
  • Revised: December 15, 2015
  • Accepted: June 5, 2016
  • DOI: 10.17795/ijcp-4211

To Cite: Aznab M, Khazaei M. Stevens-Johnson Syndrome Patient Received Combination Chemotherapy Gemcitabine, Cisplatin, and 5-FU for Biliary Tract Cancer, Int J Cancer Manag. 2016 ; 9(3):e4211. doi: 10.17795/ijcp-4211.

Abstract
Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
Footnotes
References
  • 1. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994; 331(19): 1272-85[DOI][PubMed]
  • 2. Criton S, Devi K, Sridevi PK, Asokan PU. Toxic epidermal necrolysis--a retrospective study. Int J Dermatol. 1997; 36(12): 923-5[PubMed]
  • 3. Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol. 2000; 136(3): 323-7[PubMed]
  • 4. Pruitt BA. Burn treatment for the unburned. JAMA. 1987; 257(16): 2207-28[DOI]
  • 5. Mayes T, Gottschlich M, Khoury J, Warner P, Kagan R. Energy requirements of pediatric patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Nutr Clin Pract. 2008; 23(5): 547-50[DOI][PubMed]
  • 6. Ying S, Ho W, Chan HH. Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong. Burns. 2001; 27(4): 372-5[PubMed]
  • 7. Atiyeh BS, Dham R, Yassin MF, El-Musa KA. Treatment of toxic epidermal necrolysis with moisture-retentive ointment: a case report and review of the literature. Dermatol Surg. 2003; 29(2): 185-8[PubMed]
  • 8. Boorboor P, Vogt PM, Bechara FG, Alkandari Q, Aust M, Gohritz A, et al. Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients. Burns. 2008; 34(4): 487-92[DOI][PubMed]
  • 9. Treatment efficacy in patients with advanced biliary tract cancer receiving gemcitabine and cisplatin and 21-h infusional 5-FU: An analysis of 17 cases. ASCO Annual Meeting Proceedings.
  • 10. Dietrich A, Kawakubo Y, Rzany B, Mockenhaupt M, Simon JC, Schopf E. Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp Dermatol. 1995; 4(5): 313-6[PubMed]
  • 11. Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S. Association of IL4R polymorphisms with Stevens-Johnson syndrome. J Allergy Clin Immunol. 2007; 120(6): 1457-9[DOI][PubMed]
  • 12. Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. J Am Acad Dermatol. 1991; 24(3): 457-61[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments